David Han

David Han

Direttore/Membro del Consiglio presso CELLTRION HEALTHCARE CO., LTD.
70 anni
Finance
Consumer Services
Process Industries

Profilo

Mr. David Han is an Independent Director at Celltrion Healthcare Co., Ltd. and a Co-President-Sales & Marketing at Contemporary Amperex Technology Co., Ltd. He is on the Board of Directors at Celltrion Healthcare Co., Ltd. Mr. Han was previously employed as a Senior Managing Director by OEP Capital Advisors LP, a Managing Director by Credit Suisse First Boston LLC, a Managing Director by Greenhill & Co., Inc., an Associate by Lehman Brothers, Inc., a Vice President by Morgan Stanley Investment Management, Inc., a Managing Director by Smith Barney Asset Management, and an Acquisitions Banker by Wall Street Access LLC.
He also served on the board at Birla Carbon U.S.A., Inc., Pirelli Tyres Ltd. and UNID Global Corp.
He received his undergraduate degree from Cornell University and an MBA from Harvard Business School.

Posizioni attive di David Han

SocietàPosizioneInizio
CELLTRION HEALTHCARE CO., LTD. Direttore/Membro del Consiglio 29/03/2016
CATL (CONTEMPORARY AMPEREX TECHNOLOGY) Vendite & Marketing -

Precedenti posizioni note di David Han

SocietàPosizioneFine
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
GREENHILL & CO., INC. Corporate Officer/Principal -
Investitore di Private Equity -
Vedi nel dettaglio l'esperienza di David Han

Formazione di David Han

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

15

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Finance

Finance

Finance

Finance

Finance

Finance

Consumer Services

Process Industries

Consumer Durables

Distribution Services

Health Technology

Consumer Services

Finance

Producer Manufacturing

ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA